Alexis Ji joined Illumina Ventures as a partner in 2016. She brings 13 years of experience in research and venture investment in the genomics and pharmaceutical industries. At Illumina Ventures, Alexis focuses on investing in early-stage companies in the fields of life science tools, diagnostics and therapeutics. Prior to Illumina Ventures, Alexis was a principal at WuXi Healthcare Ventures, where she focused on investments in therapeutics and medtech companies. Before joining WuXi, Alexis was a venture investment consultant at ARCH Venture Partners, where she evaluated early-stage life science and physical science opportunities. Earlier in her career, Alexis held senior scientist positions at Merck in early drug discovery, at Roche in virology translational research and clinical trial development, and at Life Technologies in molecular diagnostics and next-generation sequencing. Alexis earned her Ph.D. in Molecular Genetics from Washington University in St. Louis and an MBA from University of Chicago Booth School of Business.
Alexis is attending / has attended:
Venture Summit | West 2018
Venture Summit | West 2019